UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1691) 1691
Patent (1479) 1479
Conference Proceeding (44) 44
Book Chapter (3) 3
Technical Report (3) 3
Book / eBook (2) 2
Newspaper Article (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (785) 785
life sciences & biomedicine (704) 704
humans (601) 601
performing operations (491) 491
transporting (491) 491
male (430) 430
oncology (425) 425
female (410) 410
electricity (399) 399
physics (347) 347
chemistry (346) 346
middle aged (335) 335
metallurgy (319) 319
aged (306) 306
basic electric elements (289) 289
heating (258) 258
lighting (258) 258
blasting (257) 257
mechanical engineering (257) 257
weapons (257) 257
adult (214) 214
lung neoplasms - drug therapy (207) 207
general tagging of cross-sectional technologies spanning over several sections of the ipc (194) 194
general tagging of new technological developments (194) 194
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (194) 194
electric solid state devices not otherwise provided for (179) 179
semiconductor devices (179) 179
animals (167) 167
carcinoma, non-small-cell lung - drug therapy (166) 166
working of plastics (150) 150
working of substances in a plastic state, in general (150) 150
human necessities (133) 133
lung neoplasms - pathology (133) 133
technical subjects covered by former uspc (130) 130
after-treatment of the shaped products, e.g. repairing (125) 125
shaping of material in a plastic state, not otherwise providedfor (125) 125
shaping or joining of plastics (125) 125
technical subjects covered by former us classification (124) 124
treatment outcome (120) 120
antineoplastic combined chemotherapy protocols - therapeutic use (114) 114
hygiene (111) 111
medical or veterinary science (111) 111
cancer (108) 108
testing (103) 103
measuring (102) 102
lung cancer (101) 101
chemotherapy (99) 99
analysis (92) 92
compositions based thereon (92) 92
mice (92) 92
organic macromolecular compounds (92) 92
their preparation or chemical working-up (92) 92
combustion engines (90) 90
hot-gas or combustion-product engine plants (90) 90
carcinoma, non-small-cell lung - pathology (89) 89
electric communication technique (89) 89
aged, 80 and over (84) 84
japan (84) 84
cinematography (82) 82
electrography (82) 82
holography (82) 82
mutation (82) 82
photography (82) 82
vehicles in general (81) 81
surgery (79) 79
non-small cell lung cancer (78) 78
care and treatment (77) 77
respiratory system (77) 77
calculating (76) 76
computing (76) 76
controlling combustion engines (76) 76
counting (76) 76
lung neoplasms - genetics (76) 76
layered products (75) 75
layered products, i.e. products built-up of strata of flat ornon-flat, e.g. cellular or honeycomb, form (75) 75
lung cancer, non-small cell (73) 73
technologies or applications for mitigation or adaptation againstclimate change (73) 73
antineoplastic agents - therapeutic use (72) 72
organic chemistry (72) 72
pharmacology & pharmacy (71) 71
producing particular articles from plastics or from substancesin a plastic state (71) 71
neoplasm staging (70) 70
engineering elements and units (69) 69
general measures for producing and maintaining effectivefunctioning of machines or installations (69) 69
investigating or analysing materials by determining theirchemical or physical properties (69) 69
thermal insulation in general (69) 69
patients (68) 68
carcinoma, non-small-cell lung - genetics (65) 65
prognosis (64) 64
lung neoplasms - mortality (62) 62
medicine & public health (62) 62
research (62) 62
tumors (61) 61
indexing scheme associated with subclasses b29b, b29c or b29d, relating to moulding materials (60) 60
antineoplastic combined chemotherapy protocols - adverse effects (57) 57
optics (57) 57
cancer therapies (55) 55
disease-free survival (55) 55
ferrous or non-ferrous alloys (55) 55
treatment of alloys or non-ferrous metals (55) 55
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3095) 3095
French (246) 246
Japanese (224) 224
German (203) 203
Chinese (96) 96
Korean (19) 19
Portuguese (11) 11
Spanish (10) 10
Italian (5) 5
Arabic (1) 1
Indonesian (1) 1
Polish (1) 1
Russian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer science, ISSN 1347-9032, 03/2019, Volume 110, Issue 3, pp. 1012 - 1020
Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 2010, Volume 11, Issue 2, pp. 121 - 128
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 07/2011, Volume 29, Issue 21, pp. 2866 - 2874
Purpose The results of the Iressa Pan-Asia Study (IPASS), which compared gefitinib and carboplatin/paclitaxel in previously untreated never-smokers and light... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Immunohistochemistry | Lung Neoplasms - drug therapy | Predictive Value of Tests | Adenocarcinoma - pathology | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Time Factors | Gefitinib | Odds Ratio | Paclitaxel - administration & dosage | Adenocarcinoma - chemistry | Precision Medicine | ErbB Receptors - antagonists & inhibitors | Lung Neoplasms - chemistry | Risk Assessment | Risk Factors | Carboplatin - administration & dosage | In Situ Hybridization, Fluorescence | Logistic Models | Survival Rate | Adenocarcinoma - drug therapy | Biomarkers, Tumor - genetics | Mutation | Carcinoma, Non-Small-Cell Lung - chemistry | Adenocarcinoma of Lung | ErbB Receptors - genetics | Lung Neoplasms - pathology | Patient Selection | Female | Adenocarcinoma - genetics | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Biomarkers, Tumor - analysis | Carcinoma, Non-Small-Cell Lung - genetics | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Gene Dosage | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Asia | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | ErbB Receptors - analysis | Adenocarcinoma - mortality | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 07/2017, Volume 390, Issue 10089, pp. 29 - 39
Summary Background Alectinib, a potent, highly selective, CNS-active inhibitor of anaplastic lymphoma kinase (ALK), showed promising efficacy and tolerability... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Single-Blind Method | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Piperidines - blood | Brain Neoplasms - secondary | Pyridines - adverse effects | Carcinoma, Non-Small-Cell Lung - secondary | Neoplasm Grading | Antineoplastic Agents - adverse effects | Pyrazoles - blood | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Carbazoles - blood | Pyrazoles - adverse effects | Pyridines - therapeutic use | Carcinoma, Non-Small-Cell Lung - pathology | Carbazoles - adverse effects | Lung Neoplasms - enzymology | Kaplan-Meier Estimate | Receptor Protein-Tyrosine Kinases - metabolism | Protein Kinase Inhibitors - blood | Pyridines - blood | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Antineoplastic Agents - blood | Aged | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Medical colleges | Respiratory agents | Care and treatment | Lymphomas | Lung cancer, Non-small cell | Product development | Pharmaceutical industry | Analysis | Toxicity | Funding | Lung cancer | Central nervous system | Metastasis | Kinases | Evidence-based medicine | Recruitment | Motivation | Audio frequencies | Safety | Toxic diseases | Drug dosages | Protein-tyrosine kinase | Effectiveness | Cut-off | Data processing | Group dynamics | Patients | Survival | Lymphoma | Chemotherapy | Inhibitors | Interactive systems | Death | Mutation | Cancer | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Cancer science, ISSN 1347-9032, 01/2019, Volume 110, Issue 1, pp. 52 - 60
The efficacy of programmed cell death–1 (PD‐1) blockade in patients with non–small cell lung cancer (NSCLC) positive for epidermal growth factor receptor... 
non–small cell lung cancer | major histocompatibility complex class I | epidermal growth factor receptor | phosphatidylinositol 3‐kinase | T790M mutation | phosphatidylinositol 3-kinase | Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Lung Neoplasms - metabolism | ErbB Receptors - genetics | Lung Neoplasms - pathology | Extracellular Signal-Regulated MAP Kinases - metabolism | Histocompatibility Antigens Class I - metabolism | CD8-Positive T-Lymphocytes - metabolism | Gene Expression Regulation, Neoplastic - drug effects | Phosphorylation - drug effects | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | A549 Cells | ErbB Receptors - antagonists & inhibitors | ErbB Receptors - metabolism | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Histocompatibility Antigens Class I - genetics | Down-Regulation - drug effects | B7-H1 Antigen - genetics | B7-H1 Antigen - metabolism | MAP Kinase Signaling System - drug effects | CD8-Positive T-Lymphocytes - drug effects | Cell Line, Tumor | Protein Kinase Inhibitors - pharmacology | Mutation | CD8 antigen | Lung cancer | Lymphocytes T | mRNA | Kinases | Cancer therapies | Cell surface | Proteins | Epidermal growth factor | Immunotherapy | Protein-tyrosine kinase | Tyrosine | Antigens | Immunoglobulins | Small cell lung carcinoma | Epidermal growth factor receptors | Non-small cell lung carcinoma | Extracellular signal-regulated kinase | Gene expression | 1-Phosphatidylinositol 3-kinase | Polymerase chain reaction | Major histocompatibility complex | Cell death | Antigen (tumor-associated) | Antitumor activity | Ligands | Tumors | Apoptosis | Index Medicus | Original
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2011, Volume 29, Issue 22, pp. 2965 - 2971
Journal Article
Cancers, ISSN 2072-6694, 11/2018, Volume 10, Issue 11, p. 447
Journal Article